1832 Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-116,353
| Closed | -$16.2M | – | 661 |
|
|
2026
Q1 | $16.2M | Sell |
116,353
-43,459
| -27% | -$6.09M | 0.01% | 322 |
|
|
2025
Q4 | $19.6M | Buy |
159,812
+118,979
| +291% | +$14.5M | 0.01% | 298 |
|
|
2025
Q3 | $4.53M | Sell |
40,833
-1,467
| -3% | -$167K | ﹤0.01% | 383 |
|
|
2025
Q2 | $4.69M | Buy |
+42,300
| New | +$4.5M | ﹤0.01% | 376 |
|
|
2024
Q3 | – | Sell |
-120
| Closed | -$8.23K | – | 759 |
|
|
2024
Q2 | $8.23K | Sell |
120
-30,738
| -100% | -$2.05M | ﹤0.01% | 786 |
|
|
2024
Q1 | $2.26M | Sell |
30,858
-313
| -1% | -$24.1K | ﹤0.01% | 477 |
|
|
2023
Q4 | $2.53M | Buy |
31,171
+7,411
| +31% | +$577K | ﹤0.01% | 449 |
|
|
2023
Q3 | $1.78M | Sell |
23,760
-23,105
| -49% | -$1.78M | ﹤0.01% | 500 |
|
|
2023
Q2 | $3.61M | Buy |
46,865
+1,047
| +2% | +$83.5K | ﹤0.01% | 413 |
|
|
2023
Q1 | $3.8M | Buy |
45,818
+20,612
| +82% | +$1.71M | 0.01% | 429 |
|
|
2022
Q4 | $2.16M | Sell |
25,206
-6,961
| -22% | -$551K | ﹤0.01% | 511 |
|
|
2022
Q3 | $1.98M | Sell |
32,167
-541
| -2% | -$34.1K | ﹤0.01% | 508 |
|
|
2022
Q2 | $2.02M | Sell |
32,708
-8,363
| -20% | -$518K | ﹤0.01% | 515 |
|
|
2022
Q1 | $2.41M | Buy |
+41,071
| New | +$2.63M | ﹤0.01% | 521 |
|
|
2021
Q4 | – | Sell |
-8,933
| Closed | -$638K | – | 776 |
|
|
2021
Q3 | $638K | Buy |
+8,933
| New | +$628K | ﹤0.01% | 524 |
|
|
2021
Q1 | – | Sell |
-68,925
| Closed | -$3.92M | – | 729 |
|
|
2020
Q4 | $3.92M | Buy |
68,925
+25
| +0% | +$1.51K | 0.01% | 382 |
|
|
2020
Q3 | $4.31M | Buy |
68,900
+30,800
| +81% | +$2.14M | 0.01% | 343 |
|
|
2020
Q2 | $2.86M | Sell |
38,100
-8,000
| -17% | -$613K | 0.01% | 366 |
|
|
2020
Q1 | $3.52M | Buy |
46,100
+4,525
| +11% | +$313K | 0.01% | 332 |
|
|
2019
Q4 | $2.68M | Sell |
41,575
-1,176
| -3% | -$76.6K | 0.01% | 356 |
|
|
2019
Q3 | $2.63M | Buy |
42,751
+102
| +0.2% | +$6.67K | 0.01% | 361 |
|
|
2019
Q2 | $2.81M | Buy |
+42,649
| New | +$2.81M | 0.01% | 375 |
|
|
2019
Q1 | – | Sell |
-39,630
| Closed | -$2.62M | – | 650 |
|
|
2018
Q4 | $2.62M | Buy |
39,630
+25,596
| +182% | +$1.79M | 0.01% | 320 |
|
|
2018
Q3 | $1.24M | Sell |
14,034
-101,845
| -88% | -$7.69M | ﹤0.01% | 437 |
|
|
2018
Q2 | $8.08M | Buy |
115,879
+99,238
| +596% | +$7.01M | 0.03% | 245 |
|
|
2018
Q1 | $1.41M | Sell |
16,641
-91,605
| -85% | -$7.28M | 0.01% | 416 |
|
|
2017
Q4 | $7.66M | Buy |
108,246
+100,067
| +1,223% | +$7.6M | 0.02% | 252 |
|
|
2017
Q3 | $843K | Sell |
8,179
-275,108
| -97% | -$21M | ﹤0.01% | 439 |
|
|
2017
Q2 | $20M | Sell |
283,287
-67,485
| -19% | -$4.49M | 0.09% | 188 |
|
|
2017
Q1 | $23.9M | Sell |
350,772
-807,484
| -70% | -$56.8M | 0.09% | 183 |
|
|
2016
Q4 | $87.2M | Buy |
1,158,256
+345,550
| +43% | +$25.7M | 0.15% | 151 |
|
|
2016
Q3 | $64.3M | Sell |
812,706
-154,249
| -16% | -$12.5M | 0.24% | 102 |
|
|
2016
Q2 | $81M | Buy |
966,955
+875,419
| +956% | +$77.7M | 0.31% | 82 |
|
|
2016
Q1 | $14M | Buy |
91,536
+36,524
| +66% | +$3.29M | 0.03% | 267 |
|
|
2015
Q4 | $5.64M | Sell |
55,012
-58,324
| -51% | -$6.07M | 0.02% | 279 |
|
|
2015
Q3 | $11.2M | Sell |
113,336
-50,353
| -31% | -$5.59M | 0.05% | 223 |
|
|
2015
Q2 | $19.1M | Sell |
163,689
-576,759
| -78% | -$63M | 0.06% | 221 |
|
|
2015
Q1 | $72.8M | Sell |
740,448
-19,600
| -3% | -$1.99M | 0.27% | 94 |
|
|
2014
Q4 | $71.6M | Buy |
760,048
+661,828
| +674% | +$68.4M | 0.22% | 105 |
|
|
2014
Q3 | $10.5M | Sell |
98,220
-382,280
| -80% | -$37.4M | 0.03% | 291 |
|
|
2014
Q2 | $39.9M | Sell |
480,500
-160,900
| -25% | -$12.5M | 0.13% | 170 |
|
|
2014
Q1 | $44M | Sell |
641,400
-451,300
| -41% | -$35.4M | 0.15% | 146 |
|
|
2013
Q4 | $82.2M | Sell |
1,092,700
-65,300
| -6% | -$4.55M | 0.32% | 81 |
|
|
2013
Q3 | $72.7M | Sell |
1,158,000
-356,500
| -24% | -$21.3M | 0.32% | 84 |
|
|
2013
Q2 | $77.6M | Buy |
+1,514,500
| New | +$78.9M | 0.34% | 76 |
|
Other funds holding GILD
1832 Asset Management's GILD Position: Q2 2026 in Review
1832 Asset Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 116,353 shares — an estimated $16.2M sold.
1832 Asset Management first reported a position in GILD in Q2 2013 and held it in 45 quarters. The position peaked at $87.2M in Q4 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- 1832 Asset Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- 1832 Asset Management sold 116,353 Gilead Sciences shares in Q2 2026, an estimated $16.2M.
- 1832 Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 45 quarters.
- 1832 Asset Management's Gilead Sciences position peaked at $87.2M in Q4 2016.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.